Development of an EGFRvIII specific recombinant antibody

BACKGROUND: EGF receptor variant III (EGFRvIII) is the most common variant of the EGF receptor observed in human tumors. It results from the in frame deletion of exons 2-7 and the generation of a novel glycine residue at the junction of exons 1 and 8. This novel juxtaposition of amino acids within t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Puja, Han, Shuang-Yin, Holgado-Madruga, Marina, Mitra, Siddhartha S, Li, Gordon, Nitta, Ryan T, Wong, Albert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959087/
https://www.ncbi.nlm.nih.gov/pubmed/20925961
http://dx.doi.org/10.1186/1472-6750-10-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959087/
https://www.ncbi.nlm.nih.gov/pubmed/20925961
http://dx.doi.org/10.1186/1472-6750-10-72

Ejemplares similares